Cyclic di-GMP: Second messenger extraordinaire

Nature Reviews Microbiology

Volumn 15, Issue 5, 2017, Pages 271-284

  Jenal, Urs ^a   Reinders, Alberto ^a   Lori, Christian ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC DINUCLEOTIDE GMP; CYCLIC GMP; DINUCLEOTIDE; PHOSPHODIESTERASE; UNCLASSIFIED DRUG; BIS(3',5')-CYCLIC DIGUANYLIC ACID; CYCLIC DIADENOSINE PHOSPHATE; CYCLIC GUANOSINE MONOPHOSPHATE-ADENOSINE MONOPHOSPHATE; CYCLIC NUCLEOTIDE; DINUCLEOSIDE PHOSPHATE;

BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CAULOBACTER VIBRIOIDES; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL MATURATION; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SECOND MESSENGER; ANALOGS AND DERIVATIVES; BACTERIUM; BIOFILM; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BACTERIA; BIOFILMS; CYCLIC GMP; DINUCLEOSIDE PHOSPHATES; GENE EXPRESSION REGULATION, BACTERIAL; NUCLEOTIDES, CYCLIC; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 85011565122     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2016.190     Document Type: Review

References (227)

1. Ross, P. et al. Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature 325, 279-281 (1987).
2. Witte, G., Hartung, S., Büttner, K. & Hopfner, K.-P. Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. Mol. Cell 30, 167-178 (2008).
3. Davies, B. W., and Bogard, R. W., Young, T. S. & Mekalanos, J. J. Coordinated regulation of accessory genetic elements produces cyclic dinucleotides for V. cholerae virulence. Cell 149, 358-370 (2012).
4. Hornung, V., Hartmann, R., Ablasser, A. & Hopfner, K.-P. OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids. Nat. Rev. Immunol. 14, 521-528 (2014).
5. Chan, C. et al. Structural basis of activity and allosteric control of diguanylate cyclase. Proc. Natl Acad. Sci. USA 101, 17084-17089 (2004).
6. Kranzusch, P. J. et al. Structure-guided reprogramming of human cGAS dinucleotide linkage specificity. Cell 158, 1011-1021 (2014).
7. Paul, R. Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain. Genes Dev. 18, 715-727 (2004).
8. Christen, M., Christen, B., Folcher, M., Schauerte, A. & Jenal, U. Identification and characterization of a cyclic di-GMP-specific phosphodiesterase and its allosteric control by GTP. J. Biol. Chem. 280, 30829-30837 (2005).
9. Lori, C. et al. Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replication. Nature 523, 236-239 (2015).
10. Srivastava, D. & Waters, C. M. A tangled web: regulatory connections between quorum sensing and cyclic di-GMP. J. Bacteriol. 194, 4485-4493 (2012).
11. Gupta, K. R., Kasetty, S. & Chatterji, D. Novel functions of (p)ppGpp and cyclic di-GMP in mycobacterial physiology revealed by phenotype microarray analysis of wild-type and isogenic strains of Mycobacterium smegmatis. Appl. Environ. Microbiol. 81, 2571-2578 (2015).
12. An, S.-Q. et al. A cyclic GMP-dependent signalling pathway regulates bacterial phytopathogenesis. EMBO J. 32, 2430-2438 (2013).
13. Almblad, H. et al. The cyclic AMP-Vfr signaling pathway in Pseudomonas aeruginosa is inhibited by cyclic di-GMP. J. Bacteriol. 197, 2190-2200 (2015).
14. Römling, U., Galperin, M. Y. & Gomelsky, M. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol. Mol. Biol. Rev. 77, 1-52 (2013).
15. Corrigan, R. M. & Gründling, A. Cyclic di-AMP: another second messenger enters the fray. Nat. Rev. Microbiol. 11, 513-524 (2013).
16. Cai, X., Chiu, Y.-H. & Chen, Z. J. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 54, 289-296 (2014).
17. Danilchanka, O. & Mekalanos, J. J. Cyclic dinucleotides and the innate immune response. Cell 154, 962-970 (2013).
18. Kalia, D. et al. Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem. Soc. Rev. 42, 305-341 (2013).
19. Schirmer, T. c-di-GMP synthesis: structural aspects of evolution, catalysis and regulation. J. Mol. Biol. 428, 3683-3701 (2016).
20. Gentner, M., and Allan, M. G., Zaehringer, F., Schirmer, T. & Grzesiek, S. Oligomer formation of the bacterial second messenger c-di-GMP: reaction rates and equilibrium constants indicate a monomeric state at physiological concentrations. J. Am. Chem. Soc. 134, 1019-1029 (2012).
21. --modified response regulator PleD: implications for diguanylate cyclase activation, catalysis, and feedback inhibition. Structure 15, 915-927 (2007).
22. Paul, R. et al. Activation of the diguanylate cyclase PleD by phosphorylation-mediated dimerization. J. Biol. Chem. 282, 29170-29177 (2007).
23. Christen, B. et al. Allosteric control of cyclic di-GMP signaling. J. Biol. Chem. 281, 32015-32024 (2006).
24. De, N. et al. Phosphorylation-independent regulation of the diguanylate cyclase WspR. PLoS Biol. 6, e67 (2008).
25. Zähringer, F., Lacanna, E., Jenal, U., Schirmer, T. & Boehm, A. Structure and signaling mechanism of a zinc-sensory diguanylate cyclase. Structure 21, 1149-1157 (2013).
26. Dahlstrom, K. M., and Giglio, K. M., Sondermann, H. & O'Toole, G. A. The inhibitory site of a diguanylate cyclase is a necessary element for interaction and signaling with an effector protein. J. Bacteriol. 198, 1595-1603 (2016).
27. Barends, T. R. M. et al. Structure and mechanism of a bacterial light-regulated cyclic nucleotide phosphodiesterase. Nature 459, 1015-1018 (2009).
28. Sundriyal, A. et al. Inherent regulation of EAL domain-catalyzed hydrolysis of second messenger cyclic di-GMP. J. Biol. Chem. 289, 6978-6990 (2014).
29. Winkler, A. et al. Characterization of elements involved in allosteric light regulation of phosphodiesterase activity by comparison of different functional BlrP1 states. J. Mol. Biol. 426, 853-868 (2014).
30. Rao, F. et al. The functional role of a conserved loop in EAL domain-based cyclic di-GMP-specific phosphodiesterase. J. Bacteriol. 191, 4722-4731 (2009).
31. Navarro, M. V. et al. Structural basis for c-di-GMP-mediated inside-out signaling controlling periplasmic proteolysis. PLoS Biol. 9, e1000588 (2011).
32. Ryan, R. P., Fouhy, Y. & Lucey, J. F. Cell-cell signaling in Xanthomonas campestris involves an HD-GYP domain protein that functions in cyclic di-GMP turnover. Proc. Natl Acad. Sci. USA 103, 6712-6717 (2006).
33. Bellini, D. et al. Crystal structure of an HD-GYP domain cyclic-di-GMP phosphodiesterase reveals an enzyme with a novel trinuclear catalytic iron centre. Mol. Microbiol. 91, 26-38 (2013).
34. Orr, M. W. et al. Oligoribonuclease is the primary degradative enzyme for pGpG in Pseudomonas aeruginosa that is required for cyclic-di-GMP turnover. Proc. Natl Acad. Sci. USA 112, E5048-E5057 (2015).
35. Cohen, D. et al. Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 112, 11359-11364 (2015).
36. García, B. et al. Role of the GGDEF protein family in Salmonella cellulose biosynthesis and biofilm formation. Mol. Microbiol. 54, 264-277 (2004).
37. Tuckerman, J. R. et al. An oxygen-sensing diguanylate cyclase and phosphodiesterase couple for c-di-GMP control. Biochemistry 48, 9764-9774 (2009).
38. Plate, L. & Marletta, M. A. Nitric oxide modulates bacterial biofilm formation through a multicomponent cyclic-di-GMP signaling network. Mol. Cell 46, 1-12 (2012).
39. Basu Roy, A. & Sauer, K. Diguanylate cyclase NicD-based signalling mechanism of nutrient-induced dispersion by Pseudomonas aeruginosa. Mol Microbiol. 94, 771-793 (2014).
40. Mills, E., Petersen, E., Kulasekara, B. R. & Miller, S. I. A direct screen for c-di-GMP modulators reveals a Salmonella Typhimurium periplasmic l-arginine-sensing pathway. Sci. Signal. 8, ra57 (2015).
41. O'Connor, J. R., Kuwada, N. J., Huangyutitham, V., Wiggins, P. A. & Harwood, C. S. Surface sensing and lateral subcellular localization of WspA, the receptor in a chemosensory-like system leading to c-di-GMP production. Mol. Microbiol. 86, 720-729 (2012).
42. Hengge, R. et al. Systematic nomenclature for GGDEF and EAL domain-containing cyclic di-GMP turnover proteins of Escherichia coli. J. Bacteriol. 198, 7-11 (2015).
43. Boehm, A. et al. Second messenger-mediated adjustment of bacterial swimming velocity. Cell 141, 107-116 (2010).
44. Reinders, A. et al. Expression and genetic activation of cyclic di-GMP-specific phosphodiesterases in Escherichia coli. J. Bacteriol. 198, 448-462 (2016).
45. Lindenberg, S., Klauck, G., Pesavento, C, Klauck, E. & Hengge, R. The EAL domain protein YciR acts as a trigger enzyme in a c-di-GMP signalling cascade in E. coli biofilm control. EMBO J. 32, 2001-2014 (2013).
46. Chou, S.-H. & Galperin, M. Y. Diversity of cyclic di-GMP-binding proteins and mechanisms. J. Bacteriol. 198, 32-46 (2016).
47. Hengge, R. Cyclic-di-GMP reaches out into the bacterial RNA world. Sci. Signal. 3, pe44 (2010).
48. Krasteva, P. V. et al. Vibrio cholerae VpsT regulates matrix production and motility by directly sensing cyclic di-GMP. Science 327, 866-868 (2010).
49. Baraquet, C. & Harwood, C. S. Cyclic diguanosine monophosphate represses bacterial flagella synthesis by interacting with the Walker A motif of the enhancer-binding protein FleQ. Proc. Natl Acad. Sci. USA 110, 18478-18483 (2013).
50. Tschowri, N. et al. Tetrameric c-di-GMP mediates effective transcription factor dimerization to control Streptomyces development. Cell 158, 1136-1147 (2014).
51. Habazettl, J., and Allan, M. G., Jenal, U. & Grzesiek, S. Solution structure of the PilZ domain protein PA4608 complex with cyclic di-GMP identifies charge clustering as molecular readout. J. Biol. Chem. 286, 14304-14314 (2011).
52. Schumacher, M. A. & Zeng, W. Structures of the activator of K. pneumonia biofilm formation, MrkH, indicates PilZ domains involved in c-di-GMP and DNA binding. Proc. Natl Acad. Sci. USA 113, 10067-10072 (2016).
53. Duerig, A. et al. Second messenger-mediated spatiotemporal control of protein degradation regulates bacterial cell cycle progression. Genes Dev. 23, 93-104 (2009).
54. Morgan, J. L. W., McNamara, J. T. & Zimmer, J. Mechanism of activation of bacterial cellulose synthase by cyclic di-GMP. Nat. Struct. Mol. Biol. 21, 489-496 (2014).
55. An, S.-Q. et al. Novel cyclic di-GMP effectors of the YajQ protein family control bacterial virulence. PLoS Pathog. 10, e1004429 (2014).
56. Fazli, M. et al. The CRP/FNR family protein Bcam1349 is a c-di-GMP effector that regulates biofilm formation in the respiratory pathogen Burkholderia cenocepacia. Mol. Microbiol. 82, 327-341 (2011).
57. Matsuyama, B. Y et al. Mechanistic insights into c-di-GMP-dependent control of the biofilm regulator FleQ from Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 113, E209-E218 (2016).
58. Skotnicka, D. et al. A minimal threshold of c-di-GMP is essential for fruiting body formation and sporulation in Myxococcus xanthus. PLoS Genet. 12, e1006080 (2016).
59. Srivastava, D., Hsieh, M.-L, Khataokar, A., Neiditch, M. B. & Waters, C. M. Cyclic di-GMP inhibits Vibrio cholerae motility by repressing induction of transcription and inducing extracellular polysaccharide production. Mol. Microbiol. 90, 1262-1276 (2013).
60. Roelofs, K. G. et al. Systematic identification of cyclic-di-GMP binding proteins in Vibrio cholerae reveals a novel class of cyclic-di-GMP-binding ATPases associated with type II secretion systems. PLoS Pathog. 11, e1005232 (2015).
61. Jones, C. J. et al. c-di-GMP regulates motile to sessile transition by modulating MshA pili biogenesis and near-surface motility behavior in Vibrio cholerae. PLoS Pathog. 11, e1005068 (2015).
62. Wang, Y. C. et al. Nucleotide binding by the widespread high-affinity cyclic di-GMP receptor MshEN domain. Nat. Commun. 7, 12481 (2016).
63. Moscoso, J. A., Mikkelsen, H., Heeb, S., Williams, P. & Filloux, A. The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling. Environ. Microbiol. 13, 3128-3138 (2011).
64. Trampari, E. et al. Bacterial rotary export ATPases are allosterically regulated by the nucleotide second messenger cyclic-di-GMP. J. Biol. Chem. 290, 24470-24483 (2015).
65. Kirkpatrick, C. L. & Viollier, P. H. Decoding Caulobacter development. FEMS Microbiol. Rev. 36, 193-205 (2012).
66. Abel, S. et al. Regulatory cohesion of cell cycle and cell differentiation through interlinked phosphorylation and second messenger networks. Mol. Cell 43, 550-560 (2011).
67. Abel, S. et al. Bi-modal distribution of the second messenger c-di-GMP controls cell fate and asymmetry during the Caulobacter cell cycle. PLoS Genet. 9, e1003744 (2013).
68. Christen, M. et al. Asymmetrical distribution of the second messenger c-di-GMP upon bacterial cell division. Science 328, 1295-1297 (2010).
69. Paul, R. et al. Allosteric regulation of histidine kinases by their cognate response regulator determines cell fate. Cell 133, 452-461 (2008).
70. - and repolarization mechanism of flagellar morphogenesis during a bacterial cell cycle. Genes Dev. 27, 2049-2062 (2013).
71. Ozaki, S. et al. Activation and polar sequestration of PopA, a c-di-GMP effector protein involved in Caulobacter crescentus cell cycle control. Mol Microbiol. 94, 580-594 (2014).
72. Smith, S. C. et al. Cell cycle-dependent adaptor complex for ClpXP-mediated proteolysis directly integrates phosphorylation and second messenger signals. Proc. Natl Acad. Sci. USA 111, 14229-14234 (2014).
73. Dubey, B. N. et al. Cyclic di-GMP mediates a histidine kinase/phosphatase switch by noncovalent domain cross-linking. Sci. Adv. 2, e1600823 (2016).
74. Morgan, D. O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291 (1998).
75. Chen, Y. E. et al. Spatial gradient of protein phosphorylation underlies replicative asymmetry in a bacterium. Proc. Natl Acad. Sci. USA 108, 1052-1057 (2011).
76. Tsokos, C. G., Perchuk, B. S. & Laub, M. T. A. Dynamic complex of signaling proteins uses polar localization to regulate cell-fate asymmetry in Caulobacter crescentus. Dev. Cell 20, 329-341 (2011).
77. Kulasekara, B. R. et al. c-di-GMP heterogeneity is generated by the chemotaxis machinery to regulate flagellar motility. eLife 2, e01402 (2013).
78. Bush, M. J., Tschowri, N., Schlimpert, S., Flärdh, K. & Buttner, M. J. c-di-GMP signalling and the regulation of developmental transitions in streptomycetes. Nat. Rev. Microbiol. 13, 749-760 (2015).
79. Petters, T. et al. The orphan histidine protein kinase SgmT is a c-di-GMP receptor and regulates composition of the extracellular matrix together with the orphan DNA binding response regulator DigR in Myxococcus xanthus. Mol. Microbiol. 84, 147-165 (2012).
80. Hobley, L. et al. Discrete cyclic di-GMP-dependent control of bacterial predation versus axenic growth in Bdellovibrio bacteriovorus. PLoS Pathog. 8, e1002493 (2012).
81. Enomoto, G., Ni-Ni-Win, Narikawa, R. & Ikeuchi, M. Three cyanobacteriochromes work together to form a light color-sensitive input system for c-di-GMP signaling of cell aggregation. Proc. Natl Acad. Sci. USA 11 2, 8082-8087 (2015).
82. Valentini, M. & Filloux, A. Biofilms and cyclic di-GMP (c-di-GMP) signaling: lessons from Pseudomonas aeruginosa and other bacteria. J. Biol. Chem. 291, 12547-12555 (2016).
83. Russell, M. H. et al. Integration of the second messenger c-di-GMP into the chemotactic signaling pathway. mBio 4, e00001-13 (2013).
84. Paul, K., Nieto, V., Carlquist, W. C., Blair, D. F. & Harshey, R. M. The c-di-GMP binding protein YcgR controls flagellar motor direction and speed to affect chemotaxis by a "backstop brake" mechanism. Mol. Cell 38, 128-139 (2010).
85. Fang, X. & Gomelsky, M. A post-translational, c-di-GMP-dependent mechanism regulating flagellar motility. Mol. Microbiol. 76, 1295-1305 (2010).
86. Chen, Y., Chai, Y., Guo, J.-H. & Losick, R. Evidence for cyclic di-GMP-mediated signaling in Bacillus subtilis. J. Bacteriol. 194, 5080-5090 (2012).
87. Baker, A. E. et al. PilZ domain protein FlgZ mediates cyclic di-GMP-dependent swarming motility control in Pseudomonas aeruginosa. J. Bacteriol. 198, 1837-1846 (2016).
88. Martínez-Granero, F. et al. Identification of flgZ as a flagellar gene encoding a PilZ domain protein that regulates swimming motility and biofilm formation in Pseudomonas. PLoS ONE 9, e87608 (2014).
89. Pultz, I. S. et al. The response threshold of Salmonella PilZ domain proteins is determined by their binding affinities for c-di-GMP. Mol. Microbiol. 86, 1424-1440 (2012).
90. Park, J. H. et al. The cabABC operon essential for biofilm and rugose colony development in Vibrio vulnificus. PLoS Pathog. 11, e1005192 (2015).
91. Kariisa, A. T., Weeks, K. & Tamayo, R. The RNA domain Vc1 regulates downstream gene expression in response to cyclic diguanylate in Vibrio cholerae. PLoS ONE 11, e0148478 (2016).
92. Steiner, S., Lori, C., Boehm, A. & Jenal, U. Allosteric activation of exopolysaccharide synthesis through cyclic di-GMP-stimulated protein-protein interaction. EMBO J. 32, 354-368 (2013).
93. Skotnicka, D. et al. Cyclic di-GMP regulates type IV pilus-dependent motility in Myxococcus xanthus. J. Bacteriol. 198, 77-90 (2016).
94. Kazmierczak, B. I., Lebron, M. B. & Murray, T. S. Analysis of FimX, a phosphodiesterase that governs twitching motility in Pseudomonas aeruginosa. Mol. Microbiol. 60, 1026-1043 (2006).
95. Bordeleau, E. et al. Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile. J. Bacteriol. 197, 819-832 (2015).
96. Serra, D. O., and Richter, A. M., Klauck, G., Mika, F. & Hengge, R. Microanatomy at cellular resolution and spatial order of physiological differentiation in a bacterial biofilm. mBio 4, e00103-13 (2013).
97. Pesavento, C. et al. Inverse regulatory coordination of motility and curli-mediated adhesion in Escherichia coli. Genes Dev. 22, 2434-2446 (2008).
98. Vakulskas, C. A., and Potts, A. H., Babitzke, P., Ahmer, B. M. M. & Romeo, T. Regulation of bacterial virulence by Csr (Rsm) systems. Microbiol. Mol. Biol. Rev. 79, 193-224 (2015).
99. Chua, S. L. et al. In vitro and in vivo generation and characterization of Pseudomonas aeruginosa biofilm-dispersed cells via c-di-GMP manipulation. Nat. Protoc. 10, 1165-1180 (2015).
100. Chatterjee, D. et al. Mechanistic insight into the conserved allosteric regulation of periplasmic proteolysis by the signaling molecule cyclic-di-GMP. eLife 3, e03650 (2014).
101. Malone, J. G. et al. YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa. PLoS Pathog. 6, e1000804 (2010).
102. Blanka, A. et al. Constitutive production of c-di-GMP is associated with mutations in a variant of Pseudomonas aeruginosa with altered membrane composition. Sci. Signal. 8, ra36 (2015).
103. Bordeleau, E., Fortier, L.-C., Malouin, F. & Burrus, V. c-di-GMP turn-over in Clostridium difficile is controlled by a plethora of diguanylate cyclases and phosphodiesterases. PLoS Genet. 7, e1002039 (2011).
104. Purcell, E. B., and McKee, R. W., McBride, S. M., Waters, C. M. & Tamayo, R. Cyclic diguanylate inversely regulates motility and aggregation in Clostridium difficile. J. Bacteriol. 194, 3307-3316 (2012).
105. Soutourina, O. A. et al. Genome-wide identification of regulatory RNAs in the human pathogen Clostridium difficile. PLoS Genet. 9, e1003493 (2013).
106. Purcell, E. B., and McKee, R. W., Bordeleau, E., Burrus, V. & Tamayo, R. Regulation of type IV pili contributes to surface behaviors of historical and epidemic strains of Clostridium difficile. J. Bacteriol. 198, 565-577 (2015).
107. McKee, R. W., and Mangalea, M. R., Purcell, E. B., Borchardt, E. K. & Tamayo, R. The second messenger cyclic di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. J. Bacteriol. 195, 5174-5185 (2013).
108. Peltier, J. et al. Cyclic diGMP regulates production of sortase substrates of Clostridium difficile and their surface exposure through ZmpI protease-mediated cleavage. J. Biol. Chem. 290, 24453-24469 (2015).
109. Buchholz, U. et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N. Engl. J. Med. 365, 1763-1770 (2011).
110. Richter, A. M., and Povolotsky, T. L., Wieler, L. H. & Hengge, R. Cyclic-di-GMP signalling and biofilm-related properties of the Shiga toxin-producing 2011 German outbreak Escherichia coli O104:H4. EMBO Mol. Med. 6, 1622-1637 (2014).
111. Jenal, U. & Malone, J. Mechanisms of cyclic-di-GMP signaling in bacteria. Annu. Rev. Genet. 40, 385-407 (2006).
112. Hengge, R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol. 7, 263-273 (2009).
113. Lee, E. R., and Baker, J. L., Weinberg, Z., Sudarsan, N. & Breaker, R. R. An allosteric self-splicing ribozyme triggered by a bacterial second messenger. Science 329, 845-848 (2010).
114. Li, L. et al. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs. Nat. Chem. Biol. 10, 1043-1048 (2014).
115. Ohana, P. et al. Identification of a novel triterpenoid saponin from Pisum sativum as a specific inhibitor of the diguanylate cyclase of Acetobacter xylinum. Plant Cell Physiol. 39, 144-152 (1998).
116. Lieberman, O. J., and Orr, M. W., Wang, Y. & Lee, V. T. High-throughput screening using the differential radial capillary action of ligand assay identifies ebselen as an inhibitor of diguanylate cyclases. ACS Chem. Biol. 9, 183-192 (2014).
117. He, Q. et al. Structural and biochemical insight into the mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP phosphodiesterase. J. Biol. Chem. 291, 3668-3681 (2016).
118. Huynh, T. N. et al. An HD-domain phosphodiesterase mediates cooperative hydrolysis of c-di-AMP to affect bacterial growth and virulence. Proc. Natl Acad. Sci. USA 112, E747-E756 (2015).
119. Bai, Y. et al. Two DHH subfamily 1 proteins in Streptococcus pneumoniae possess cyclic di-AMP phosphodiesterase activity and affect bacterial growth and virulence. J. Bacteriol. 195, 5123-5132 (2013).
120. Mehne, F. M. P. et al. Cyclic di-AMP homeostasis in Bacillus subtilis: both lack and high level accumulation of the nucleotide are detrimental for cell growth. J. Biol. Chem. 288, 2004-2017 (2013).
121. Witte, C. E. et al. Cyclic di-AMP is critical for Listeria monocytogenes growth, cell wall homeostasis, and establishment of infection. mBio 4, 3, e00025-12 (2012).
122. Haake, D. A. & Matsunaga, J. Leptospira: a spirochaete with a hybrid outer membrane. Mol. Microbiol. 77, 805-814 (2010).
123. Slamti, L., de Pedro, M. A., Guichet, E. & Picardeau, M. Deciphering morphological determinants of the helix-shaped Leptospira. J. Bacteriol. 193, 6266-6275 (2011).
124. Jutras, B. L. et al. Lyme disease and relapsing fever Borrelia elongate through zones of peptidoglycan synthesis that mark division sites of daughter cells. Proc. Natl Acad. Sci. USA 113, 9162-9170 (2016).
125. Motaleb, M. A. et al. Borrelia burgdorferi periplasmic flagella have both skeletal and motility functions. Proc. Natl Acad. Sci. USA 97, 10899-10904 (2000).
126. Zhao, X., Norris, S. J. & Liu, J. Molecular architecture of the bacterial flagellar motor in cells. Biochemistry 53, 4323-4333 (2014).
127. Moon, K. H. et al. Spirochetes flagellar collar protein FlbB has astounding effects in orientation of periplasmic flagella, bacterial shape, motility, and assembly of motors in Borrelia burgdorferi. Mol. Microbiol. 102, 336-348 (2016).
128. Raddi, G. et al. Three-dimensional structures of pathogenic and saprophytic Leptospira species revealed by cryo-electron tomography. J. Bacteriol. 194, 1299-1306 (2012).
129. Malmström, J. et al. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature 460, 762-765 (2009).
130. Charon, N. W. & Goldstein, S. F. Genetics of motility and chemotaxis of a fascinating group of bacteria: the spirochetes. Annu. Rev. Genet. 36, 47-73 (2002).
131. Lambert, A. et al. FlaA proteins in Leptospira interrogans are essential for motility and virulence but are not required for formation of the flagellum sheath. Infect. Immun. 80, 2019-2025 (2012).
132. Wunder, E. A. Jr et al. A novel flagellar sheath protein, FcpA, determines filament coiling, translational motility and virulence for the Leptospira spirochete. Mol. Microbiol. 101, 457-470 (2016).
133. Goldstein, S. F. & Charon, N. W. Motility of the spirochete Leptospira. Cell Motil. Cytoskeleton 9, 101-110 (1988).
134. Nakamura, S., Leshansky, A., Magariyama, Y., Namba, K. & Kudo, S. Direct measurement of helical cell motion of the spirochete Leptospira. Biophys. J. 106, 47-54 (2014).
135. Goldstein, S. F. & Charon, N. W. Multiple-exposure photographic analysis of a motile spirochete. Proc. Natl Acad. Sci. USA 87, 4895-4899 (1990).
136. Beck, M. et al. Visual proteomics of the human pathogen Leptospira interrogans. Nat. Methods 6, 817-823 (2009).
137. Costa, T. R. et al. Secretion systems in Gram-negative bacteria: structural and mechanistic insights. Nat. Rev. Microbiol. 13, 343-359 (2015).
138. Abby, S. S. et al. Identification of protein secretion systems in bacterial genomes. Sci. Rep. 6, 23080 (2016).
139. Bulach, D. M. et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc. Natl Acad. Sci. USA 103, 14560-14565 (2006).
140. Bierne, H., Sabet, C., Personnic, N. & Cossart, P. Internalins: a complex family of leucine-rich repeat-containing proteins in Listeria monocytogenes. Microbes Infect. 9, 1156-1166 (2007).
141. Miras, I. et al. Structural characterization of a novel subfamily of leucine-rich repeat proteins from the human pathogen Leptospira interrogans. Acta Crystallogr. D Biol. Crystallogr. 71, 1351-1359 (2015).
142. Lehmann, J. S. et al. Pathogenomic inference of virulence-associated genes in Leptospira interrogans. PLoS Negl. Trop. Dis. 7, e2468 (2013).
143. Satou, K. et al. Complete genome sequences of low-passage virulent and high-passage avirulent variants of pathogenic Leptospira interrogans serovar Manilae strain UP-MMC-NIID, originally isolated from a patient with severe leptospirosis, determined using PacBio single-molecule real-time technology. Genome Announc. 3, e00882-15 (2015).
144. Toma, C., Okura, N., Takayama, C. & Suzuki, T. Characteristic features of intracellular pathogenic Leptospira in infected murine macrophages. Cell. Microbiol. 13, 1783-1792 (2011).
145. Barocchi, M. A., and Ko, A. I., Reis, M. G., McDonald, K. L. & Riley, L. W. Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen. Infect. Immun. 70, 6926-6932 (2002).
146. Li, S. et al. Replication or death: distinct fates of pathogenic Leptospira strain Lai within macrophages of human or mouse origin. Innate Immun. 16, 80-92 (2010).
147. Asoh, T. et al. Natural defense by saliva and mucosa against oral infection by Leptospira. Can. J. Microbiol. 60, 383-389 (2014).
148. Charon, N. W., and Greenberg, E. P., Koopman, M. B. H. & Limberger, R. J. Spirochete chemotaxis, motility, and the structure of the spirochetal periplasmic flagella. Res. Microbiol. 143, 597-603 (1992).
149. Fraga, T. R., Barbosa, A. S. & Isaac, L. Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system. Scand. J. Immunol. 73, 408-419 (2011).
150. Kassegne, K. et al. Identification of collagenase as a critical virulence factor for invasiveness and transmission of pathogenic Leptospira species. J. Infect. Dis. 209, 1105-1115 (2014).
151. Wunder, E. A. J. et al. Real-time PCR reveals rapid dissemination of Leptospira interrogans after intraperitoneal and conjunctival inoculation of hamsters. Infect. Immun. 84, 2105-2115 (2016).
152. Athanazio, D. A. et al. Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop. 105, 176-180 (2008).
153. Pinne, M. & Haake, D. A. LipL32 is a subsurface lipoprotein of Leptospira interrogans: presentation of new data and reevaluation of previous studies. PLoS ONE 8, e51025 (2013).
154. Murray, G. L. The molecular basis of leptospiral pathogenesis. Curr. Top. Microbiol. Immunol. 387, 139-185 (2015).
155. Fernandes, L. G. et al. Leptospira spp.: novel insights into host-pathogen interactions. Vet. Immunol. Immunopathol. 176, 50-57 (2016).
156. Matsunaga, J. et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol. Microbiol. 49, 929-945 (2003).
157. Ptak, C. P. et al. NMR solution structure of the terminal immunoglobulin-like domain from the Leptospira host-interacting outer membrane protein, LigB. Biochemistry 53, 5249-5260 (2014).
158. Choy, H. A. et al. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun. 75, 2441-2450 (2007).
159. Choy, H. A. et al. The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans. PLoS ONE 6, e16879 (2011).
160. Castiblanco-Valencia, M. M. et al. Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP. J. Infect. Dis. 205, 995-1004 (2012).
161. Ching, A. T. et al. Leptospira interrogans shotgun phage display identified LigB as a heparin-binding protein. Biochem. Biophys. Res. Commun. 427, 774-779 (2012).
162. Croda, J. et al. Targeted mutagenesis in pathogenic Leptospira: disruption of the ligB gene does not affect virulence in animal models of leptospirosis. Infect. Immun. 76, 5826-5833 (2008).
163. Figueira, C. P. et al. Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin. BMC Microbiol. 11, 129 (2011).
164. Castiblanco-Valencia, M. M. et al. Acquisition of negative complement regulators by the saprophyte Leptospira biflexa expressing LigA or LigB confers enhanced survival in human serum. Immunol. Lett. 173, 61-68 (2016).
165. Robbins, G. T. et al. Evaluation of cell binding activities of Leptospira ECM adhesins. PLoS Negl. Trop. Dis. 9, e0003712 (2015).
166. Breiner, D. D., Fahey, M., Salvador, R., Novakova, J. & Coburn, J. Leptospira interrogans binds to human cell surface receptors including proteoglycans. Infect. Immun. 77, 5528-5536 (2009).
167. Evangelista, K., Franco, R., Schwab, A. & Coburn, J. Leptospira interrogans binds to cadherins. PLoS Negl. Trop. Dis. 8, e267 (2014).
168. Eshghi, A. et al. Pathogenic Leptospira interrogans exoproteins are primarily involved in heterotrophic processes. Infect. Immun. 83, 3061-3073 (2015).
169. Narayanavari, S. A., Lourdault, K., Sritharan, M., Haake, D. A. & Matsunaga, J. Role of sph2 gene regulation in hemolytic and sphingomyelinase activities produced by Leptospira interrogans. PLoS Negl. Trop. Dis. 9, e0003952 (2015).
170. Gasque, P. & Jaffar-Bandjee, M. C. The immunology and inflammatory responses of human melanocytes in infectious diseases. J. Infect. 71, 413-421 (2015).
171. Li, L., Ojcius, D. M. & Yan, J. Comparison of invasion of fibroblasts and macrophages by high- and low-virulence Leptospira strains: colonization of the host-cell nucleus and induction of necrosis by the virulent strain. Arch. Microbiol. 188, 591-598 (2007).
172. Jin, D. et al. Leptospira interrogans induces apoptosis in macrophages via caspase-8- and caspase-3-dependent pathways. Infect. Immun. 77, 799-809 (2009).
173. Merien, F., Baranton, G. & Perolat, P. Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect. Immun. 65, 729-738 (1997).
174. Toma, C. et al. Leptospiral outer membrane protein LMB216 is involved in enhancement of phagocytic uptake by macrophages. Cell. Microbiol. 16, 1366-1377 (2014).
175. Zhang, L. et al. The mammalian cell entry (Mce) protein of pathogenic Leptospira species is responsible for RGD motif-dependent infection of cells and animals. Mol. Microbiol. 83, 1006-1023 (2012).
176. Xue, F. et al. Responses of murine and human macrophages to leptospiral infection: a study using comparative array analysis. PLoS Negl. Trop. Dis. 7, e2477 (2013).
177. Castiblanco-Valencia, M. M. et al. Plasmin cleaves fibrinogen and the human complement proteins C3b and C5 in the presence of Leptospira interrogans proteins: a new role of LigA and LigB in invasion and complement immune evasion. Immunobiology 221, 679-689 (2016).
178. Fraga, T. R. et al. Immune evasion by pathogenic Leptospira strains: the secretion of proteases that directly cleave complement proteins. J. Infect. Dis. 209, 876-886 (2014).
179. Fernandes, L., de Morais, Z., Vasconcellos, S. & Nascimento, A. Leptospira interrogans reduces fibrin clot formation by modulating human thrombin activity via exosite I. Pathog. Dis. 73, ftv001 (2015).
180. Scharrig, E. et al. Neutrophil extracellular traps are involved in the innate immune response to infection with Leptospira. PLoS Negl. Trop. Dis. 9, e0003927 (2015).
181. Srikram, A. et al. Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J. Infect. Dis. 203, 870-879 (2011).
182. Nally, J. E., Chow, E., Fishbein, M. C., Blanco, D. R. & Lovett, M. A. Changes in lipopolysaccharide O antigen distinguish acute versus chronic Leptospira interrogans infections. Infect. Immun. 73, 3251-3260 (2005).
183. Nahori, M. A. et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J. Immunol. 175, 6022-6031 (2005).
184. Goris, M. G. A. et al. Potent innate immune response to pathogenic Leptospira in human whole blood. PLoS ONE 6, e18279 (2011).
185. Chassin, C. et al. TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans. J. Immunol. 183, 2669-2677 (2009).
186. Needham, B. D. & Trent, M. S. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat. Rev. Microbiol. 11, 467-481 (2013).
187. Eshghi, A., Henderson, J., Trent, M. S. & Picardeau, M. Leptospira interrogans lpxD homologue is required for thermal acclimatization and virulence. Infect. Immun. 83, 4314-4321 (2015).
188. Picardeau, M. in Leptospira and Leptospirosis (ed. Adler, B.) 43-63 (Springer-Verlag Berlin Heidelberg, 2015).
189. Adler, B., Lo, M., Seemann, T. & Murray, G. L. Pathogenesis of leptospirosis: the influence of genomics. Vet. Microbiol. 153, 73-81 (2011).
190. Lo, M., and Cordwell, S. J., Bulach, D. M. & Adler, B. Comparative transcriptional and translational analysis of leptospiral outer membrane protein expression in response to temperature. PLoS Negl. Trop. Dis. 3, e560 (2009).
191. Matsunaga, J., Schlax, P. J. & Haake, D. A. Role for cis-acting RNA sequences in the temperature-dependent expression of the multiadhesive lig proteins in Leptospira interrogans. J. Bacteriol. 195, 5092-5101 (2013).
192. Schons-Fonseca, L. et al. Analysis of LexA binding sites and transcriptomics in response to genotoxic stress in Leptospira interrogans. Nucleic Acids Res. 44, 1179-1191 (2016).
193. Lourdault, K., and Cerqueira, G. M., Wunder, E. A. Jr & Picardeau, M. Inactivation of clpB in the pathogen Leptospira interrogans reduces virulence and resistance to stress conditions. Infect. Immun. 79, 3711-3717 (2011).
194. King, A. M. et al. High-temperature protein G is an essential virulence factor of Leptospira interrogans. Infect. Immun. 82, 1123-1131 (2014).
195. Lo, M. et al. Transcriptional response of Leptospira interrogans to iron limitation and characterization of a PerR homolog. Infect. Immun. 78, 4850-4859 (2010).
196. Caimano, M. J. et al. A model system for studying the transcriptomic and physiological changes associated with mammalian host-adaptation by Leptospira interrogans serovar Copenhageni. PLoS Pathog. 10, e1004004 (2014).
197. 2 and for virulence. Infect. Immun. 80, 3892-3899 (2012).
198. Eshghi, A. et al. Methylation and in vivo expression of the surface-exposed Leptospira interrogans outermembrane protein OmpL32. Microbiology 158, 622-635 (2012).
199. Cao, X. J. et al. High-coverage proteome analysis reveals the first insight of protein modification systems in the pathogenic spirochete Leptospira interrogans. Cell Res. 20, 197-210 (2010).
200. Witchell, T. D. et al. Post-translational modification of LipL32 during Leptospira interrogans infection. PLoS Negl. Trop. Dis. 8, e3280 (2014).
201. Ricaldi, J. N., and Matthias, M. A., Vinetz, J. M. & Lewis, A. L. Expression of sialic acids and other nonulosonic acids in Leptospira. BMC Microbiol. 12, 161 (2012).
202. Lindow, J. C. et al. Cathelicidin insufficiency in patients with fatal leptospirosis. PLoS Pathog. 12, e1005943 (2016).
203. Wilson, M. R. et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N. Engl. J. Med. 370, 2408-2417 (2014).
204. Ratet, G. et al. Live imaging of bioluminescent Leptospira interrogans in mice reveals renal colonization as a stealth escape from the blood defenses and antibiotics. PLoS Negl. Trop. Dis. 8, e3359 (2014).
205. Pappas, C. J., Benaroudj, N. & Picardeau, M. A replicative plasmid vector allows efficient complementation of pathogenic Leptospira strains. Appl. Environ. Microbiol. 81, 3176-3781 (2015).
206. Pappas, C. J. & Picardeau, M. Control of gene expression in Leptospira spp. by transcription activator-like effectors (TALEs) demonstrates a potential role for LigA and LigB in virulence in L. interrogans. Appl. Environ. Microbiol. 81, 7888-7892 (2015).
207. Lourdault, K., Matsunaga, J. & Haake, D. A. High-throughput parallel sequencing to measure fitness of Leptospira interrogans transposon insertion mutants during acute infection. PLoS Negl. Trop. Dis. 10, e0005117 (2016).
208. Picardeau, M. in The Prokaryotes (ed. Rosenberg, E.) 711-729 (Springer-Verlag Berlin, 2014).
209. Bharti, A. R. et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3, 757-771 (2003).
210. Levett, P. N. Leptospirosis. Clin. Microbiol. Rev. 14, 296-326 (2001).
211. De la Peña-Moctezuma, A., Bulach, D. M., Kalambaheti, T. & Adler, B. Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis. FEMS Microbiol. Lett. 177, 319-326 (1999).
212. Llanes, A., Restrepo, C. M. & Rajeev, S. Whole genome sequencing allows better understanding of the evolutionary history of Leptospira interrogans serovar Hardjo. PLoS ONE 11, e0159387 (2016).
213. Galloway, R. L. & Levett, P. N. Evaluation of a modified pulsed-field gel electrophoresis approach for the identification of Leptospira serovars. Am. J. Trop. Med. Hyg. 78, 628-632 (2008).
214. Herrmann, J. L., Bellenger, E., Perolat, P., Baranton, G. & Saint Girons, I. Pulsed-field gel electrophoresis of NotI digests of leptospiral DNA: a new rapid method of serovar identification. J. Clin. Microbiol. 30, 1696-1702 (1992).
215. Schmid, G. P. et al. Newly recognized Leptospira species ("Leptospira inadai" serovar lyme) isolated from human skin. J. Clin. Microbiol. 24, 484-486 (1986).
216. Matthias, M. A. et al. Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the peruvian Amazon. PLoS Negl. Trop. Dis. 2, e213 (2008).
217. Paster, B. J. et al. Phylogenetic analysis of the spirochetes. J. Bacteriol. 173, 6101-6109 (1991).
218. Yasuda, P. H. et al. Deoxyribonucleic acid relatedness between serogroups and serovars in the family Leptospiraceae with proposals for seven new Leptospira species. Int. J. Syst. Bacteriol. 37, 407-415 (1987).
219. Brenner, D. J. et al. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies. Int. J. Syst. Bacteriol. 49, 839-858 (1999).
220. Boonsilp, S. et al. A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species. PLoS Negl. Trop. Dis. 7, e1954 (2013).
221. Ahmed, N. et al. Multilocus sequence typing method for identification and genotypic classification of pathogenic Leptospira species. Ann. Clin. Microbiol. Antimicrob. 5, 28 (2006).
222. Rettinger, A. et al. Leptospira spp. strain identification by MALDI TOF MS is an equivalent tool to 16S rRNA gene sequencing and multi locus sequence typing (MLST). BMC Microbiol. 12, 185 (2012).
223. Richter, M. & Rosselló-Móra, R. Shifting the genomic gold standard for the prokaryotic species definition. Proc. Natl Acad. Sci. USA 106, 19126-19131 (2009).
224. Bourhy, P., Collet, L., Brisse, S. & Picardeau, M. Leptospira mayottensis sp. nov., a pathogenic Leptospira species isolated from humans. Int. J. Syst. Evol. Microbiol. 64, 4061-4067 (2014).
225. Ristow, P. et al. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog. 3, e97 (2007).
226. Murray, G. L. et al. The major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect. Immun. 77, 952-958 (2009).
227. Murray, G. L. et al. Leptospira interrogans requires heme oxygenase for disease pathogenesis. Microbes Infect. 11, 311-314 (2009).